216 related articles for article (PubMed ID: 17320115)
41. Adherence: a necessity for successful HIV combination therapy.
Chesney MA; Ickovics J; Hecht FM; Sikipa G; Rabkin J
AIDS; 1999; 13 Suppl A():S271-8. PubMed ID: 10885784
[TBL] [Abstract][Full Text] [Related]
42. HIV clinic improves medication adherence. DOT is latest experimental strategy.
AIDS Alert; 2005 Mar; 20(3):28-9. PubMed ID: 15789471
[TBL] [Abstract][Full Text] [Related]
43. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
44. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
[TBL] [Abstract][Full Text] [Related]
45. Expanding role of conformulations in the treatment of HIV infection: impact of fixed-dose combinations.
Valenti WM
AIDS Read; 2004 Oct; 14(10):541-3, 547-50. PubMed ID: 15510390
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
47. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
[TBL] [Abstract][Full Text] [Related]
48. Simplifying drug regimens goal of research.
Gaylord G
Posit Living; 1999 Nov; 8(10):6, 56. PubMed ID: 11367337
[TBL] [Abstract][Full Text] [Related]
49. High antiretroviral drug adherence key in effort to avoid drug resistance. New study highlights its importance.
AIDS Alert; 2005 Mar; 20(3):25, 27-8. PubMed ID: 15789470
[TBL] [Abstract][Full Text] [Related]
50. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
51. Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
Chaix ML; Desquilbet L; Descamps D; Costagliola D; Deveau C; Galimand J; Goujard C; Signori-Schmuck A; Schneider V; Tamalet C; Pellegrin I; Wirden M; Masquelier B; Brun-Vezinet F; Rouzioux C; Meyer L; ;
Antivir Ther; 2007; 12(8):1305-10. PubMed ID: 18240870
[TBL] [Abstract][Full Text] [Related]
52. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
Townsend ML; Jackson GL; Smith R; Wilson KH
Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
[TBL] [Abstract][Full Text] [Related]
53. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
[TBL] [Abstract][Full Text] [Related]
54. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
55. Adherence to highly active antiretroviral therapy.
Williams AB
Nurs Clin North Am; 1999 Mar; 34(1):113-29. PubMed ID: 9922282
[TBL] [Abstract][Full Text] [Related]
56. Adherence to HAART.
Proj Inf Perspect; 1997 Jul; (22):20-3. PubMed ID: 11364576
[TBL] [Abstract][Full Text] [Related]
57. Adherence to HIV drug therapy.
Gross R
LDI Issue Brief; 2002 Nov; 8(3):1-4. PubMed ID: 12530426
[TBL] [Abstract][Full Text] [Related]
58. Switching antiretroviral therapy: why, when and how.
Wilkin T; Glesby M; Gulick RM
IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
[No Abstract] [Full Text] [Related]
59. [Quality of life as the focus of modern anti-HIV treatment. More compact regimens for therapy success].
MMW Fortschr Med; 2001 Sep; 143(35-36):58-9. PubMed ID: 11584536
[No Abstract] [Full Text] [Related]
60. HIV adherence survey findings at a glance.
AIDS Alert; 2001 Jun; 16(6):77, 70. PubMed ID: 11569968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
